This process upregulates cell adhesion molecules (ICAM-1 and VCAM-1), the death receptor Fas, and MHC I and II, thereby enhancing the recruitment and activation of innate immune cells and tumor-specific lymphocytes [42,43,44,45]. The gene discussed is ICAM1; the disease is neoplasm.